Lv31
248 积分 2020-07-27 加入
How should we approach the treatment of IgAN in 2025?
3天前
已关闭
Costal Chondrocyte–Derived Pellet-Type Autologous Chondrocyte Implantation Versus Microfracture for the Treatment of Articular Cartilage Defects: A 5-Year Follow-up of a Prospective Randomized Trial
11天前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
19天前
已完结
The promises and challenges of neoantigen cancer vaccines
19天前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
22天前
已完结
Benzoheterocyclic analogues of dotinurad as orally efficacious human urate transporter 1 inhibitors: Design, synthesis, structure-activity relationships, and pharmacokinetic studies
29天前
已关闭
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture
1个月前
已完结
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial
1个月前
已完结
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial
1个月前
已完结
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial
1个月前
已完结
皖公网安备34019202002308
